Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age8-10
SponsorEmory University
About this trial
The goal of this project is to measure the clinical utility of an objective and quantitative eye-tracking assay collected on a standalone, mobile investigational device to accurately screen 9-month-old infants for autism spectrum disorder and other actionable delays.
Eligibility criteria
Qualifiers
Infants between the chronological ages of 8-10 months
Infants must be generally healthy with no acute illnesses likely to prevent successful or valid data collection (e.g., current vomiting, high fever, conjunctivitis affecting vision)
Participants' parents/caregivers must be able to understand and voluntarily provide written informed consent.
Disqualifiers
None
Trial design
Treatments tested in this trial
- EarliPoint Investigational Device
Treatment groups
2,120 Participants
are divided into 1 treatment groupSponsors and collaborators
Emory University
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov